26.72
+0.71(+2.73%)
Currency In USD
| Previous Close | 26.01 |
| Open | 26.11 |
| Day High | 26.79 |
| Day Low | 25.77 |
| 52-Week High | 27.51 |
| 52-Week Low | 13.86 |
| Volume | 1.22M |
| Average Volume | 1.6M |
| Market Cap | 2.3B |
| PE | 43.1 |
| EPS | 0.62 |
| Moving Average 50 Days | 22.24 |
| Moving Average 200 Days | 22.2 |
| Change | 0.71 |
If you invested $1000 in Progyny, Inc. (PGNY) since IPO date, it would be worth $1,676.29 as of December 13, 2025 at a share price of $26.72. Whereas If you bought $1000 worth of Progyny, Inc. (PGNY) shares 5 years ago, it would be worth $658.61 as of December 13, 2025 at a share price of $26.72.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
GlobeNewswire Inc.
Nov 20, 2025 2:23 PM GMT
75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers.NEW YORK, Nov.
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
GlobeNewswire Inc.
Nov 13, 2025 5:33 PM GMT
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
GlobeNewswire Inc.
Oct 23, 2025 5:08 PM GMT
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the ma